Simple and smart next-level PRRSV vaccine monitoring is here.
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) inflicts severe economic damage on the pork industry every year; causing respiratory illness in piglets and reproductive failure in sows. Early detection and targeted control are essential.
At INDICAL, we’re excited to launch the innovative virotype PRRSV EU Vax RT-PCR Kit, for detection and differentiation of major PRRSV-1 vaccines in a fast, accurate and cost-effective manner. Used in combination with the virotype PRRSV 2.0 RT-PCR Kit, it delivers a smarter way to DIVA and confirm vaccination status, saving time and money in the lab and supporting confident herd health decisions.
Learn more about the product here.
Today INDICAL is taking the first step into food safety and antimicrobial resistance segments by joining forces with Check-Points.
Check-Points is a Dutch R&D focused company that produces tests for two principal markets – food safety and human antimicrobial resistance. The main component of the business is related to “Check and Trace”, a unique product based on a microarray platform to accurately identify over 300 serotypes of Salmonella. The company, founded in 2002 with annual revenues of approximately EUR 2.3 million, also produces a number of DNA-based tests for the molecular detection of antimicrobial resistance in hospital acquired infections in humans.
Through the Salmonella test, the company principally serves producers and labs within the poultry industry as well as food safety labs. The human assays principally target in-hospital laboratories.
“The acquisition of Check-Points bolsters our poultry portfolio and direct-to-producer offering. Check-Points has developed strong momentum in its core products and has an exciting R&D pipeline, with highly relevant development expertise that can support new projects within INDICAL itself. We look forward to working with the Check-Points management team to take advantage of all these opportunities”, says Stefano Santarelli, CEO of INDICAL BIOSCIENCE.
Antimicrobial resistance (AMR) is a global health and development threat that requires urgent action in order to achieve the Sustainable Development Goals (SDGs) and is declared as one of the top 10 global public health threats facing humanity by the World Health Organization (WHO). Having Check-Points as part of the family is a great step towards INDICAL’s contribution to One Health – of the planet, animals and people.
Read the full press release here
INDICAL is proud to enter a strategic partnership with pioneering air sampling technology company AeroCollect.
The technology enables detection of pathogens earlier than clinical symptoms or shedding of pathogens. Results are gathered through a 3-step method that does not compromise on animal welfare.
- Walk around the farm for 5 minutes with the instrument to collect the sample
- Send sample to laboratory
- Get same day results for presence of bacteria or viruses
“The pioneering technology will facilitate easier, faster and more accurate sampling in vet diagnostics to support our ambition to improve animal health globally”, says Stefano Santarelli, CEO of INDICAL BIOSCIENCE.
Read the full press release here
AeroCollect in action
AeroCollect® works by pulling a flow of air through a small sample chamber. When collecting samples, high voltage is applied to the test chamber. This creates an electric field across the sample chamber that captures and concentrates bacteria, viruses, and other microscopic particles in the sample chamber. The sample chamber is then sent to the laboratory where the content is analysed for pathogens using a qPCR analysis. The results are ready within one to two hours.
Watch the clip below to see how it works
https://vimeo.com/669780165Learn more about the AeroCollect device here
